Triple

T22871284
Position Surface form Disambiguated ID Type / Status
Subject CYP2C9 E567200 entity
Predicate inducedBy P92780 FINISHED
Object carbamazepine NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: carbamazepine | Statement: [CYP2C9, inducedBy, carbamazepine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: carbamazepine
Context triple: [CYP2C9, inducedBy, carbamazepine]
  • A. carbamazepine chosen
    Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
  • B. lamotrigine
    Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
  • C. phenytoin
    Phenytoin is an antiepileptic medication commonly used to prevent and control seizures by stabilizing neuronal activity in the brain.
  • D. valproate
    Valproate is an anticonvulsant and mood-stabilizing medication widely used to treat epilepsy, bipolar disorder, and to prevent migraine headaches.
  • E. vigabatrin
    Vigabatrin is an antiepileptic medication that irreversibly inhibits GABA transaminase to increase brain GABA levels, used mainly for refractory seizures such as infantile spasms but associated with risks like permanent visual field loss.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e24589d8348190b96422d13a678bc1 completed April 17, 2026, 2:36 p.m.
NER Named-entity recognition batch_69f17f05c688819097ba3d24ea8e52f5 completed April 29, 2026, 3:46 a.m.
Created at: April 17, 2026, 3:38 p.m.